Summary
Preserving vision throughout life does not depend on a single supplement, eye exercise, or technological device. Eye health consists of several different elements, including the health of the ocular surface and tear film, optical focusing, retinal and macular health, optic nerve function, metabolic and vascular health, and sufficiently early detection of eye diseases.
The effects of screens on the eyes also need to be discussed precisely. Prolonged screen work can increase eye dryness, fatigue, burning, headaches, and temporary blurred vision. However, these symptoms do not automatically indicate eye damage. Digital eye strain is primarily associated with prolonged near work, reduced or incomplete blinking, tear film disturbances, and strain caused by the work environment and ergonomics.(3–6)
Based on current evidence, blue light from screens is not the primary cause of digital eye strain, and normal exposure to blue light from typical displays has not been shown to damage the retina. Bright light in the evening can, however, affect melatonin secretion, circadian rhythm, and sleep onset.(11–13)
More important factors for long-term visual health include not smoking, maintaining metabolic health, good management of diabetes and blood pressure, physical activity, a high-quality diet, sufficient sleep, reducing UV exposure, and appropriate eye examinations.(1,2,18,19)
For supplements, the evidence is indication-specific. AREDS2-type supplementation has clinical evidence for use in certain people with age-related macular degeneration, but the same benefit cannot be generalized to healthy eyes. The evidence for omega-3 fatty acids in dry eye disease is more mixed, while astaxanthin has promising but clearly more limited evidence for eye strain and focusing ability.(27–33)
Emerging technologies also need to be matched to the correct problem. Photobiomodulation is being studied for dry age-related macular degeneration, IPL and thermal pulsation treatments for meibomian gland dysfunction, and specific optical solutions for progressive childhood myopia. Repeated low-level red-light therapy is an interesting new myopia-control method, but long-term safety and post-treatment effects still require careful monitoring.(34–43)
DISCLAIMER
This article is intended for general health and wellness information. It does not replace an individual examination, diagnosis, or treatment provided by an ophthalmologist, optometrist, or other healthcare professional.
Sudden vision loss or a major change in vision, new flashes of light together with a sudden increase in floaters, a curtain or shadow appearing in the visual field, and severe eye pain especially when accompanied by a change in vision require prompt medical assessment. Symptoms consistent with retinal detachment should not be monitored at home.(1,44)
Introduction: Eye Health Is Not One Single Thing
Eye health is often discussed too simplistically. People talk about “screen eyes,” blue light, eye vitamins, or aging eyes as if they all represented one biological phenomenon.
In reality, the eye consists of several structures with completely different functions. The cornea and the tear film covering it affect ocular surface comfort and optical quality. The lens is responsible for focusing and is involved in presbyopia and cataracts. The retina converts light into neural signals, and the macula is especially responsible for precise central vision. The optic nerve transmits visual information from the eye to the brain.(1,2)
This leads to an important practical principle: “eye wellness” should not be treated as one universal target with one universal solution.
Dry eye disease, presbyopia, cataract, glaucoma, age-related macular degeneration, and progressive childhood myopia are different conditions. Their biological mechanisms, risk factors, diagnostic methods, and treatments differ from each other.(1,2)
Good decision-making therefore starts with three questions: which eye structure or function do you want to support, what specific benefit are you trying to achieve, and which intervention fits that particular situation?
This distinction helps place nutrition, supplements, screen habits, and emerging technologies in the correct context.
Vision Changes Throughout Life
The priorities of the visual system change with age.
In childhood, the main issue is eye growth and the development of myopia. In middle age, near-focusing capacity begins to decline. Later in life, cataracts, glaucoma, and macular diseases become increasingly important.(1,2,14)
However, not all age-related changes are diseases.
Presbyopia Is a Normal Physiological Change
When looking at something close, the eye must increase its refractive power. In a young eye, the lens can change shape efficiently: ciliary muscle activity allows the lens to become more rounded and focus a nearby object onto the retina.
With age, the lens becomes less flexible. The eye can no longer increase its refractive power as effectively, which makes focusing at near distances more difficult. This is called presbyopia.
A typical practical sign is holding text farther away and eventually needing reading glasses or another form of near correction. This does not mean that a computer, smartphone, or reading has “worn out” the eye. It is primarily a normal age-related change in the lens and focusing system.(1,2)
This distinction is important because ordinary presbyopia should not be confused with eye disease.
Cataract, Glaucoma, and Age-Related Macular Degeneration Are Not the Same Disease
Three well-known eye diseases become more common with age, but they affect different structures.
Cataract means clouding of the lens. It can cause blurred vision, glare, reduced contrast sensitivity, and changes in color perception.
Glaucoma is a disease that damages the optic nerve. A particular challenge is that it can progress significantly without obvious subjective symptoms. Visual field loss is often detected only at a later stage.
Age-related macular degeneration, or AMD, affects the macular area. It can cause distortion of central vision, loss of fine detail, and in more advanced stages, significant loss of central vision.(1,2)
Grouping all three diseases together as “aging eyes” easily leads to incorrect conclusions. Cataract requires different management from glaucoma. Glaucoma monitoring differs from AMD monitoring. A supplement that may have a role in a specific stage of AMD does not treat cataract or glaucoma.
Precise diagnosis matters.
Lack of Symptoms Does Not Always Mean Healthy Eyes
One particular challenge in eye disease prevention is that subjective symptoms are not a perfect screening method.
Some significant eye diseases can progress for a long time without clear symptoms. Glaucoma is a classic example. Retinal and other ocular changes can also be detected during examinations before a person notices major visual decline.(1)
The need for eye examinations depends on age, family history, medical conditions, medications, ocular findings, and previous disease history.
According to the American Academy of Ophthalmology guidance used in the webinar, a general schedule for comprehensive eye examinations in asymptomatic adults without particular risk factors is approximately every 5–10 years before age 40, every 2–4 years at ages 40–54, every 1–3 years at ages 55–64, and every 1–2 years from age 65 onward. Risk factors, symptoms, or an established eye disease may require much more frequent monitoring. Local clinical practices may also differ.(1)
The goal is not to examine everyone as often as possible. The goal is to detect disease early enough when earlier detection can change the outcome.
Digital Eye Strain: A Real Symptom Complex Without Unnecessary Fear of Screens
Digital devices have become a central part of work, education, and leisure. At the same time, dryness, eye fatigue, fluctuating focus, and headaches are very common during prolonged screen use.
Digital eye strain refers to a group of recurring eye and visual symptoms associated with the use of digital devices. It is not a single disease.(3,6)
Typical symptoms include eye dryness and a gritty sensation, burning or irritation, heavy and tired eyes, temporary blurred vision, headaches associated with visual load, and slower refocusing from near to far.(3–6)
These symptoms can be completely real and functionally significant even when there is no tissue damage in the eye. Persistent symptoms can interfere with concentration, slow prolonged visual work, and reduce quality of life.(6)
For this reason, the question should not be framed as “do screens damage the eyes?” but more precisely: what is it about screen use that is straining my visual system?
Why Does Screen Work Strain the Eyes?
Digital eye strain usually results from a combination of several factors.
The first mechanism is prolonged near work. The eyes must maintain accommodation and binocular coordination at the same distance for extended periods. The smaller the text, the less suitable the viewing distance, or the longer the uninterrupted work period, the more continuously the visual system has to work.(3–6)
The second key factor is changes in blinking. During intensive visual and cognitive work, blink frequency may decrease, and especially the proportion of incomplete blinks may increase. This can reduce tear film stability and increase ocular surface drying.(3,4,7)
The third factor is the visual environment. Small text, poor contrast, strong reflections, airflow directed toward the eyes, dry indoor air, or a screen whose brightness differs greatly from ambient lighting can increase symptoms.(3,4)
The fourth factor is cognitive concentration. When a task absorbs attention, a person may work for long periods with very little movement and stare at the same distance without natural interruptions. Blinking, changes in posture, and looking into the distance also decrease.
The primary solution is therefore not buying a new product. A good starting point is to reduce the strain of the visual task itself.
The Tear Film Is Part of the Eye’s Optical System
The tear film is not simply “moisture on the surface of the eye.” It forms an optically important interface over the cornea.
Traditionally, tear film function can be described in terms of a lipid component, an aqueous component, and a mucin- and glycocalyx-related surface. The lipid layer reduces evaporation and helps smooth the surface. The aqueous portion hydrates the surface and carries substances dissolved in the tears. Mucin and glycocalyx structures help the tear film spread evenly over the cornea.
Blinking spreads and renews the tear film. If blinking repeatedly remains incomplete, tear film smoothness and stability may deteriorate. In a 2025 study, a higher proportion of incomplete blinks was associated with the likelihood of dry eye disease and several ocular surface findings, while blink rate alone was less explanatory.(7)
This supports the practical idea that blink quality may in some situations matter more than the number of blinks alone.
Small randomized studies have found that computer- or app-based blink reminders and blink training can improve blinking behavior and reduce symptoms related to dry eye. However, the studies are still small, and training should not replace evaluation of actual dry eye disease.(8,9)
A Practical Blink Reset
A simple technique is a conscious, complete blink.
First relax the forehead and the area around the eyes. Then gently close the eyelids completely without forceful squeezing. Keep them closed for a brief moment and open the eyes slowly.
Repeat this a few times, especially when you notice your eyes becoming dry during intensive computer work.
The goal is not to create a new compulsive ritual. The aim is to restore more normal and complete blinking when intense concentration has reduced it.
Blue Light: Separate Eye Strain, Sleep, and Retinal Safety
Discussion about blue light often suffers from mixing together three completely different questions.
The first question concerns digital eye strain: does filtering blue light reduce dryness, burning, headaches, or visual fatigue?
The second concerns sleep and circadian rhythm: can reducing short-wavelength light in the evening improve sleep onset or sleep timing?
The third concerns long-term retinal health: does filtering blue light prevent macular disease or other retinal damage?
These three questions should not be given one common answer.
Blue Light From Screens Is Not the Main Cause of Digital Eye Strain
Displays produce short-wavelength visible light, but ordinary daylight is generally a much more intense source of blue light than a screen. Under measured normal-use conditions, exposure from computers, tablets, and similar light sources has remained far below photochemical damage thresholds.(12)
Dryness and visual fatigue associated with screen use fit much better with prolonged near work, reduced blinking, ocular surface drying, and ergonomic factors.(3–6)
For this reason, buying blue-light glasses does not remove the main causes of screen-related strain.
What Did the Cochrane Review Find About Blue-Light Glasses?
A 2023 Cochrane review examined 17 randomized trials involving a total of 619 participants. The studies were relatively small and so heterogeneous that a unified meta-analysis could not be performed.(11)
For short-term eye strain, the evidence did not show a clear clinical benefit from blue-light filtering lenses. The review also found some signals of a possible sleep benefit, but the results were inconsistent and the certainty of evidence was low. In addition, the studies did not assess structural changes in the macula in a way that would allow conclusions about long-term “macular protection.”(11)
Based on current evidence, blue-light glasses should therefore not be considered a general treatment for digital eye strain.
Evening Light Is a Different Question From Eye Damage
The fact that blue light from screens has not been shown to damage the retina during normal use does not mean evening light is biologically irrelevant.
The circadian system responds to light. Bright evening light can reduce melatonin secretion and shift biological timing later. The effect depends on the timing, duration, intensity, and spectrum of exposure.(13)
In a well-known controlled study, using a light-emitting e-reader before sleep, compared with reading a printed book, led to reduced melatonin, delayed circadian timing, and longer sleep-onset latency, among other effects.(13)
This is primarily a sleep and circadian-rhythm issue, not evidence of retinal damage.
In practice, it is reasonable to reduce unnecessarily bright light in the evening, lower screen brightness, and use a warmer color temperature when needed. Even more important is to consider the lighting of the entire environment rather than focusing only on the blue component of a smartphone display.
Make the Screen Easier to Look At Before Trying to Tolerate It for Longer
Good screen ergonomics can be reduced to four basic factors: text readability, appropriate viewing distance, screen position, and balanced lighting.(3,4)
Text should be large enough that the eyes do not need to constantly “force focus.” The screen should be positioned at a comfortable distance rather than as close as possible. The top of the screen can generally be slightly below eye level, reducing the need to maintain an upward gaze. Screen brightness should also match the surrounding room.
A simple practical test works surprisingly well: if the screen looks like a separate light source in a dark room rather than part of the environment, the brightness difference is probably unnecessarily large.
Reflections should also be removed. A window or bright light reflecting from the screen can increase visual strain even when the screen settings themselves are appropriate.
Interrupt Prolonged Near Work
The main purpose of a break is not to satisfy some magical minute quota. The most important point is to interrupt continuous near focusing.
A good short break changes several things at the same time. The gaze moves farther away. Blinking returns toward normal. Posture changes. The neck and shoulders move. Cognitive focus briefly detaches from the same task.
For this reason, a purposeful break of a few dozen seconds may be more useful than a break during which a person simply switches from a computer to a smartphone.
The 20–20–20 Rule Is a Reminder, Not a Physiological Law
The familiar 20–20–20 rule means that after about 20 minutes of near work, you look at something about 20 feet, or six meters, away for at least 20 seconds.
The exact numbers should not be interpreted as biological threshold values. In a small prospective study, 20–20–20 reminders reduced symptoms associated with digital eye strain, but most objective ocular surface findings did not change significantly.(10)
The most useful way to apply the rule is to think of it as a behavioral reminder: regularly interrupt long periods of uninterrupted near work.
A 60-Second Screen Reset
When eye fatigue begins to increase during the workday, perform a quick check.
Text: enlarge the text if you notice yourself leaning forward or squinting. Light: reduce reflections and balance the brightness difference between the room and the screen. Distance: return the screen and your body to a comfortable position. Blinking: perform a few slow, complete blinks. Break: look far enough away to let your focusing system change distance.
This sequence requires no special device or supplement. It first corrects the simplest and most likely causes of strain.(3,4)
Long-Term Eye Health Starts With Whole-Body Health
When discussing long-term eye health, screen hacks can easily receive disproportionate attention.
The retina is a highly active, richly vascularized neural tissue. Its health is not separate from glucose metabolism, blood pressure, vascular health, smoking, nutrition, or general systemic health.
This is why the most important strategies for preserving long-term vision often look familiar: do not smoke, take care of blood pressure and metabolic health, exercise, eat a nutrient-dense diet, sleep enough, and protect the eyes from excessive UV exposure.(1,2,18,19)
This may sound less exotic than a new light-therapy device or eye supplement, but the range of effects is much broader.
Smoking Is a Major Modifiable Eye-Health Risk
Smoking is among the important modifiable risk factors for eye disease. Research reviews have linked it especially with age-related eye disorders, including age-related macular degeneration.(18,19)
From the perspective of the eyes, smoking cessation should therefore not be viewed only as a lung- and cardiovascular-health intervention. It also supports preservation of vision.
Diabetes and Blood Pressure Also Affect the Eyes
Diabetes can damage the small blood vessels of the retina and lead to diabetic retinopathy. For this reason, regular eye monitoring is part of good diabetes care.(1,2)
Blood pressure and broader cardiovascular health also matter. Daily choices that improve metabolism and vascular function simultaneously support the biological environment of the retina.
Eye health is therefore not a separate optimization project. It is part of metabolic and cardiovascular health.
Sleep Also Supports Eye Function
Sleep affects the eyes through several mechanisms.
In a controlled study, acute sleep deprivation reduced tear secretion and impaired the tear film. This supports the association between insufficient sleep and ocular surface disturbances.(20)
Sleep deprivation also affects motor control of the visual system. In one study, acute sleep deprivation and circadian misalignment impaired several measures related to tracking moving targets and coordinated eye movements.(21)
The role of sleep for the eyes is therefore both local and neurological.
Healthy adults are advised to obtain at least seven hours of sleep per night on a regular basis. The recommendation is 9–12 hours for children aged 6–12 and 8–10 hours per 24 hours for adolescents aged 13–18.(22,23)
In practice, a good foundation is to reserve enough time for sleep, keep wake time as regular as possible, obtain natural daylight during the day, and keep the bedroom dark, cool, and quiet.(24)
UV Protection Is a Long-Term Strategy
The eyes are exposed to a large cumulative amount of ultraviolet radiation from sunlight over a lifetime. The cornea and lens absorb a significant proportion of UV radiation, which makes reducing UV exposure a sensible part of long-term eye protection.
In strong sunlight, sunglasses should ideally carry a UV400 label or state 99–100% UVA and UVB protection. Larger frames or frames that also shield from the sides reduce lateral exposure.
Lens darkness does not indicate the quality of UV protection. A dark lens without proper UV filtering is not the same as effective UV protection.
The goal of UV protection is not to treat sunlight as an enemy, but to reduce unnecessary cumulative UV exposure to ocular tissues.(1)
Childhood Myopia: Screen Time, Near Work, and Outdoor Time
The increasing prevalence of childhood myopia is one of the most important current vision-health issues.
Here too, it is important to distinguish between association and direct causation.
A 2025 systematic review and dose-response meta-analysis included 45 studies and more than 335,000 participants. Each additional hour of digital screen time per day was associated on average with about 21% higher odds of myopia. However, much of the evidence was observational, so the finding does not mean that light from screens directly damages the eye or that a single universal “safe screen-time” threshold can be defined for every child.(15)
Screen time often also serves as a partial marker for the amount of near work, time spent indoors, and reduced outdoor time.
Outdoor Time Is One of the Best-Supported Preventive Strategies
Evidence for outdoor time is particularly interesting. Meta-analyses have long shown that spending more time outdoors is associated with a lower risk of developing myopia.(14,17)
In a 2024 meta-analysis of outdoor interventions, seven randomized trials involving 9,437 children showed that outdoor interventions reduced the incidence of myopia; the pooled relative risk was approximately 0.84.(16)
Outdoor time appears to work better for preventing the onset of myopia than for treating myopia that is already clearly progressing.
The practical message for parents is straightforward: ensure that a child has regular outdoor time and interrupt prolonged periods of near work. The issue does not need to be framed as fear of “screen radiation.”
If myopia is progressing, however, outdoor time alone may not always be sufficient. In that situation, clinical assessment for myopia control is needed.
Nutrition and Eye Health
Eye health cannot be separated from nutrition, but no single nutrient should be elevated into a universal solution for the entire visual system.
A good starting point is a nutrient-dense dietary pattern that provides the retina with needed micronutrients, essential fatty acids, and antioxidant compounds while also supporting blood pressure, glucose metabolism, and vascular health.
Reviews of Mediterranean-style diets have found that stronger adherence is associated with a lower risk of age-related eye diseases and particularly age-related macular degeneration. Much of the evidence is observational, so these findings should not be interpreted as a drug-like treatment effect.(25,26)
In practice, an eye-supportive diet can include plenty of colorful vegetables and berries, dark green leafy vegetables, high-quality protein sources, fish, nuts, extra-virgin olive oil, and individually suitable whole grains and legumes.
Lutein and Zeaxanthin: Macular Carotenoids
Lutein and zeaxanthin are xanthophyll carotenoids that accumulate in the macula and contribute to the formation of macular pigment.
Macular pigment absorbs part of short-wavelength visible light and contributes to antioxidant protection of the retina. Lutein and zeaxanthin intake can increase macular pigment optical density, but a biological effect does not automatically mean that supplementation prevents eye disease in every healthy user.(27,31)
Good dietary sources include especially dark green leafy vegetables and other vegetables containing yellow and green carotenoids.
An important distinction applies here: the biological role of a nutrient and the demonstrated clinical benefit of a supplement are two different things.
DHA and EPA From the Perspective of the Retina
DHA is an important structural fatty acid in the cell membranes of retinal photoreceptors. It contributes to membrane structure and function and to lipid balance in the visual system.
EPA does not have quite the same direct structural abundance in photoreceptors, but EPA and DHA both participate in regulation of inflammatory responses and lipid-mediated signaling.
This provides a strong biological rationale for adequate intake of omega-3 fatty acids. It does not, however, mean that high-dose omega-3 supplementation prevents all retinal diseases or treats dry eye disease in everyone.
Clinical evidence must be evaluated separately for each indication.(27–30)
Vitamin C, Vitamin E, Zinc, and Copper
Vitamins C and E participate in the body’s antioxidant systems. Zinc is also relevant to several biological processes in the retina and retinal pigment epithelium.
Their best-known role in clinical eye-health research comes particularly from the AREDS and AREDS2 trials.
Copper has a somewhat different role in the AREDS formulation: one reason it is included is to prevent copper deficiency associated with high-dose zinc.
This again emphasizes why research findings from a supplement combination should not be broken apart into claims that each individual component produces the same clinical effect on its own.(27,28)
AREDS2: One of the Best-Studied Eye Supplement Interventions — but Only in the Right Situation
AREDS2 is a good example of how supplementation needs to be evaluated according to disease stage and target population.
The AREDS2-type daily dose discussed in the webinar contains 10 mg lutein, 2 mg zeaxanthin, 500 mg vitamin C, 400 IU vitamin E, 80 mg zinc, and 2 mg copper.(27,28)
A central clinical finding from the AREDS research program is an approximately 25% relative reduction in the risk of progression to advanced AMD over around five years in certain higher-risk groups. The benefit particularly applies to patients who already have intermediate or otherwise clinically significant age-related macular degeneration.(27,28)
This does not mean that every adult should take an AREDS2 product “just in case.”
The benefit-risk balance is not the same for a healthy person, someone with early AMD, someone with intermediate AMD, and someone with advanced disease. The appropriate formulation and indication should be evaluated with a professional based on retinal findings.
AREDS2 is therefore a good example of a targeted supplement, not a general eye vitamin.
Omega-3 for Dry Eye: The Biological Rationale Is Stronger Than the Consistency of the Clinical Evidence
EPA and DHA contribute to cell-membrane structure and regulation of inflammatory responses. For this reason, omega-3 supplements have been extensively studied for dry eye disease.
The findings are not fully consistent.
In the large DREAM trial, omega-3 supplementation did not provide a significant advantage over the control group for symptoms of dry eye disease.(29)
On the other hand, later systematic reviews and meta-analyses have found average improvements in some symptom and tear-film measures. However, the doses, formulations, patient populations, and dry-eye mechanisms differ across studies.(30)
The best conclusion is therefore not “omega-3 works” or “omega-3 does not work.”
The benefit appears to be individual. If omega-3 supplementation is tried as part of dry-eye management, it is useful to define the outcome in advance: do burning, foreign-body sensation, or other symptoms decrease enough to provide a meaningful practical benefit?
Astaxanthin and Eye Strain
Astaxanthin is a carotenoid that has been studied in relation to focusing ability and symptoms associated with digital eye strain.
In adults, an older study found that 6 mg per day for four weeks was associated with improved accommodative function compared with placebo.(32)
In a randomized, double-blind, placebo-controlled study published in 2025, children aged 10–14 with at least four hours of daily screen time and symptoms consistent with digital eye strain used 4 mg of astaxanthin per day for 84 days. The study found improvements in digital-eye-strain symptom scores and visual fatigue compared with placebo. The study included 64 children.(33)
The result is interesting, but the evidence is still clearly more limited than, for example, the disease-specific evidence for AREDS2.
Astaxanthin should therefore not take priority over screen ergonomics, sufficient breaks, or proper evaluation of actual dry eye disease. Supplement use in children should also be planned together with a professional.
Eye Technologies: Diagnose First, Then Choose the Device
Eye-health technologies are developing rapidly. At the same time, there is a growing risk that devices developed for different purposes are grouped together as one category of “eye wellness technology.”
The order should be reversed.
First define the ocular problem and mechanism. Then choose the technology.
Retinal disease, meibomian gland dysfunction, and progressive childhood myopia are not the same problem. Their device-based treatments should not be the same either.
Photobiomodulation for Dry Age-Related Macular Degeneration
Photobiomodulation, or PBM, uses red and/or near-infrared light to produce a biological response in tissue.
The rationale behind retinal PBM research includes modulation of mitochondrial energy production, cellular stress, and inflammatory responses.
At present, one of the most interesting ocular applications is non-exudative, or dry, AMD.
In the LIGHTSITE III trial, multiwavelength PBM was associated with a statistically significant visual-acuity advantage over sham treatment at 13 months.(34)
Later systematic reviews and meta-analyses support a possible benefit, but the studies remain heterogeneous and the overall evidence continues to develop.(35)
Two important limitations follow from this.
First, retinal PBM is not a general “red-light treatment for screen eyes.” The studied indication is disease-specific.
Second, PBM does not replace established treatments for eye disease. It does not replace, for example, anti-VEGF therapy for wet AMD, cataract surgery, or appropriate ophthalmic follow-up.
High-intensity light therapy directed at the eye should not be approached with the same logic as general red-light treatment for skin or muscles. Use around the eyes belongs to carefully dosed and clinically justified protocols.
Meibomian Gland Dysfunction: Thermal Pulsation and IPL
In many people with dry eye, the main problem is not simply insufficient tear production but meibomian gland dysfunction, or MGD.
The meibomian glands produce the lipid component of the tear film. If their secretion thickens or the glands become obstructed, the tear film may evaporate too quickly.
In this situation, office-based treatments that target the underlying mechanism may make sense.
Thermal pulsation warms the eyelids and aims to evacuate obstructed meibomian gland secretions. Systematic reviews support the possibility of improving symptoms and gland function in selected patients.(37)
IPL, or intense pulsed light, is applied around the eyelids and is used particularly for MGD-related dry eye, often together with gland expression. A systematic review and meta-analysis support the possibility of clinically meaningful symptom benefit.(36)
However, these are not the first solution for every person whose eyes feel tired at a computer.
The mechanism should first be identified. If the real problem is an uncorrected refractive error, poor working conditions, or another eye disease, using a meibomian-gland device will not address the root cause.
Progressive Childhood Myopia Can Now Also Be Treated
Myopia management has changed rapidly. In the past, a child’s myopia might simply be corrected with standard single-vision glasses while clinicians monitored how much stronger the prescription became each year.
Today, the goal can also be to slow axial elongation of the eye.
This matters because higher myopia is associated with greater long-term risk of retinal and other ocular diseases.
DIMS and Other Lenslet Spectacle Lenses
In DIMS-type glasses, the optical design creates a myopia-control defocus signal on the retina in addition to ordinary refractive correction.
Randomized trials and newer meta-analyses show that these myopia-control spectacle lenses can slow both refractive progression and axial elongation compared with standard single-vision lenses.(38,39)
The practical advantage is ease of use: the child wears the glasses normally without the hygiene burden associated with contact lenses.
Orthokeratology
Orthokeratology uses specially designed rigid contact lenses worn overnight to temporarily reshape the optical profile of the cornea.
Meta-analyses show that the method can slow axial elongation in myopic children and adolescents.(40)
However, the method is more demanding than spectacles. Because it involves overnight contact-lens wear, good hygiene, proper fitting, and regular monitoring are essential.
A randomized study published in 2026 compared a DIMS-type lens solution with orthokeratology, illustrating how actively myopia-control options are now being studied against each other.(41)
If a child’s myopia is clearly progressing, years of passive waiting are no longer the only option.
Repeated Low-Level Red Light for Childhood Myopia
Repeated low-level red-light therapy, or RLRL, is one of the newest myopia-control technologies.
In studies, the eyes are exposed to precisely dosed red light according to a defined protocol. The aim is to influence biological mechanisms regulating eye growth and slow axial elongation.
A 2026 meta-analysis of randomized trials showed a clear efficacy signal for slowing myopia progression and axial elongation, particularly during the first year.(42)
This does not mean that any red-light device is suitable for a child’s eyes.
For ocular exposure, dosage, wavelength, device optics, treatment duration, and monitoring are critical. Safety reviews have reported mostly mild and transient adverse effects, but rare retinal changes have also been described. More information is needed about long-term retinal safety and rebound after treatment discontinuation.(42,43)
RLRL should therefore be viewed as a potential clinical myopia-management tool, not a general red-light biohack for home use.
OCT and Eye Monitoring: Measure the Right Thing
One of the most important technological developments in eye health is not a treatment device but better measurement.
Optical coherence tomography, or OCT, produces cross-sectional images of retinal structure. It allows examination of different retinal layers, the macula, and in many applications also optic-nerve structures.
Structural imaging is complemented by functional measurements. Visual acuity describes one aspect of visual performance. Visual-field testing helps assess functional changes associated with conditions such as glaucoma.
A single measurement is often less informative than comparison of repeated measurements in the same person. Follow-up shows whether structure or visual function is changing and how quickly the change is occurring.(1)
This is a good example of a basic principle of health optimization: measure the outcome that the intervention is actually supposed to change.
When Should Eye Symptoms Be Evaluated Promptly?
Most fatigue or dryness associated with screen work is not an emergency.
However, some symptoms should not be ignored.
Sudden or severe loss of vision requires prompt assessment. The same applies to severe eye pain accompanied by a change in vision.
A particularly important combination is new flashes of light and the sudden appearance of many new floaters. If a curtain- or shadow-like area also appears in the visual field, this may indicate a retinal tear or retinal detachment. Urgent ophthalmic examination is then required.(44)
Milder symptoms should also be evaluated if they persist, worsen, interfere with normal daily life, or are new and unexplained.
Continually experimenting with products and devices is not a good substitute for proper examination.
A Practical Priority Order for Protecting Vision
A good eye-health strategy can be built step by step.
The first level is the whole-body foundation. Avoid smoking, manage blood pressure and glucose metabolism, exercise, eat well, sleep sufficiently, and control excessive UV exposure. These factors influence long-term visual health more broadly than most individual eye products.(1,2,18,19,25)
The second level is the screen environment. Make text large enough, reduce reflections, match screen brightness to the environment, maintain a comfortable viewing distance, and interrupt prolonged near-work periods.(3,4,6)
The third level is the ocular surface. Pay attention to complete blinking and investigate persistent dry eye symptoms. If MGD is present, treatment should be targeted to that mechanism.(7–9,36,37)
The fourth level is nutrition. Build the foundation with overall dietary quality first. Use targeted supplements when there is a sufficient indication.(25–31)
The fifth level is disease-specific technology. PBM, IPL, thermal pulsation, DIMS spectacles, orthokeratology, and RLRL apply to different problems. Choose the technology only after the target has been defined.(34–43)
The sixth level is monitoring. Define in advance what benefit the intervention should produce. This may be reduced symptoms, improved tear-film function, preserved visual function, slower axial elongation, or slower structural progression of disease.
Without a defined goal, it is impossible to know whether an intervention is working.
Summary
The most important shift in protecting vision is to move from the vague concept of “eye wellness” to more precise questions.
The ocular surface, lens, retina, macula, and optic nerve are different tissues. Their problems feel different and require different solutions.
With screen use, the most important symptoms typically relate to near work, the tear film, blinking, and ergonomics. Blue light from screens has not been shown to be the main cause of digital eye strain, and normal screen exposure does not, based on current evidence, cause retinal damage. Evening light is, however, relevant to circadian rhythm and sleep.(3–6,11–13)
For long-term visual health, attention should shift to larger factors. Smoking, diabetes, blood pressure, metabolism, nutrition, sleep, UV exposure, and adequate eye monitoring matter more than most marketed eye hacks.(1,2,18–26)
For supplements, both overstatement and understatement should be avoided. Lutein, zeaxanthin, omega-3 fatty acids, vitamins, and minerals have real biological functions in the eye, but biological relevance alone does not prove a clinical benefit from supplementation. AREDS2 is a good example of how a meaningful benefit can be achieved in the right disease stage and target population.(27–31)
Precision also matters with technology. Photobiomodulation may become useful for dry AMD. IPL and thermal pulsation can help in correctly diagnosed MGD. DIMS lenses and orthokeratology can slow childhood myopia progression. RLRL may become an important new option if long-term safety and correct dosing can be defined sufficiently well.(34–43)
Ultimately, the best overall strategy for eye health is very similar to a good health strategy in general: build a strong foundation, identify the actual problem, choose an appropriate intervention, and measure whether the desired outcome changes.
Scientific References
1. American Academy of Ophthalmology Preferred Practice Pattern Committee. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern®. Approved 2025; published 2026. DOI: 10.1016/j.ophtha.2025.12.031.
2. World Health Organization. Blindness and vision impairment. Fact sheet. Updated 10 February 2026.
3. Wolffsohn JS, Lingham G, Downie LE, et al. TFOS Lifestyle: Impact of the digital environment on the ocular surface. The Ocular Surface. 2023;28:213–252. DOI: 10.1016/j.jtos.2023.04.004.
4. Kamøy B, Magno M, Nøland ST, et al. Video display terminal use and dry eye: preventive measures and future perspectives. Acta Ophthalmologica. 2022;100(7):723–739. DOI: 10.1111/aos.15105.
5. Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The Relationship Between Dry Eye Disease and Digital Screen Use. Clinical Ophthalmology. 2021;15:3811–3820. PMID 34531649.
6. Pucker AD, et al. Digital Eye Strain: Updated Perspectives. 2024. PMID 39308959.
7. Wang MTM, et al. Blink completeness and rate in dry eye disease: prospective registry-based cross-sectional prognostic study. 2025. PMID 39799007.
8. Efficacy of blink software in improving blink rate and dry eye symptoms in visual display terminal users: a single-blinded randomized controlled trial. 2021. PMID 34571605.
9. A smartphone-based blink training application for alleviating dry eye signs and symptoms. Prospective randomized study. 2025. PMID 41266739.
10. Talens-Estarelles C, Cerviño A, García-Lázaro S, et al. The effects of breaks on digital eye strain, dry eye and binocular vision: Testing the 20-20-20 rule. Contact Lens Anterior Eye. 2023;46(2):101744. PMID 35963776.
11. Singh S, Keller PR, Busija L, et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev. 2023;8:CD013244. PMID 37593770.
12. O’Hagan JB, Khazova M, Price LLA. Low-energy light bulbs, computers, tablets and the blue light hazard. Eye. 2016.
13. Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. 2015.
14. Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Ophthalmology. 2017;124(7):1036–1057.
15. Ha A, Lee YJ, Lee M, et al. Digital Screen Time and Myopia: A Systematic Review and Dose-Response Meta-Analysis. JAMA Network Open. 2025;8(2):e2460026. PMID 39982728.
16. Mei Z, et al. Efficacy of outdoor interventions for myopia in children and adolescents: systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2024. PMID 39193200.
17. Martinez-Perez C, Sanchez-Tena MA, Sánchez-González JM, et al. Influence of outdoor time on spherical equivalent and axial length in childhood myopia: a meta-analysis. Acta Ophthalmol. 2025. PMID 40066935.
18. Gong Y, Li J, Sun Y, et al. Smoking, dietary factors and major age-related eye disorders: an umbrella review of systematic reviews and meta-analyses. Br J Ophthalmol. 2023;107:151–159.
19. Risk factors for age-related macular degeneration: updated systematic review and meta-analysis. 2025. PMID 39993131.
20. Lee YB, et al. Sleep deprivation reduces tear secretion and impairs the tear film. IOVS. 2014.
21. Stone LS, et al. Distinct pattern of oculomotor impairment associated with acute sleep loss and circadian misalignment. J Physiol. 2019.
22. AASM/SRS. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement. 2015.
23. American Academy of Sleep Medicine. Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement. 2016.
24. National Heart, Lung, and Blood Institute. Healthy Sleep Habits. 2022.
25. Wu Y, Xie Y, Yuan Y, et al. The Mediterranean Diet and Age-Related Eye Diseases: A Systematic Review. Nutrients. 2023;15(9):2043. PMID 37432187.
26. Dinu M, et al. Adherence to the Mediterranean-Style Eating Pattern and Macular Degeneration: A Systematic Review of Observational Studies. Nutrients. 2022. PMID 35631175.
27. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005–2015.
28. Vavvas DG, Kim IK, et al. What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review. Acta Ophthalmologica. 2022;100(7):e1456–e1468.
29. Dry Eye Assessment and Management Study Research Group. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med. 2018;378:1681–1690. PMID 29652551.
30. García-Medina JJ, et al. Omega-3 fatty acids in the management of dry eye disease: updated systematic review and meta-analysis. Acta Ophthalmol. 2022. PMID 36147013.
31. Effect of xanthophyll-rich food and supplement intake on visual outcomes in healthy adults and those with eye disease: systematic review, meta-analysis and meta-regression of RCTs. Nutrients. 2023. PMID 37094947.
32. Nagaki Y, et al. Study examining the effects of astaxanthin on accommodative function. J Clin Ther Med. 2006;22:41–54.
33. Hecht KA, et al. Astaxanthin improved acute and chronic digital eye strain in children: randomized double-blind placebo-controlled trial. Adv Ther. 2025;42:1811–1833. PMID 40014233.
34. Boyer DS, et al. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative Dry AMD. Retina. 2024. PMID 37972955.
35. Chen K-Y, Lee HK, Chan H-C, et al. Is Multiwavelength Photobiomodulation Effective and Safe for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis. Ophthalmol Ther. 2025;14:969–987.
36. Rønne ST, et al. Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction: systematic review and meta-analysis. Acta Ophthalmol. 2024. PMID 39611367.
37. Cao Y, et al. Efficacy and safety of a vectored thermal pulsation system (LipiFlow®) in meibomian gland dysfunction: systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259:2645–2658. PMID 34374808.
38. Lam CSY, Tang WC, Tse DYY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104:363–368. PMID 31142465.
39. Bao J, et al. Efficacy of spectacle lenses for myopia control: a meta-analysis of randomised controlled trials. Br J Ophthalmol. 2025. PMID 40912901.
40. Zhang Y, et al. Efficacy of Orthokeratology in Controlling Axial Elongation in Myopic Children and Adolescents: A Systematic Review and Meta-Analysis. Eye Contact Lens. 2025. PMID 42589879.
41. Richter GM, et al. Defocus incorporated multiple segment spectacle lenses versus orthokeratology lenses for myopia control: a non-inferiority randomised clinical trial. Acta Ophthalmol. 2026. PMID 42595991.
42. Duration-Dependent Efficacy and Clinical Safety of Repeated Low-Level Red-Light Therapy for Paediatric Myopia: systematic review and meta-analysis of RCTs. 2026. PMID 41846466.
43. Chen Y, et al. Safety of repeated low-level red-light therapy for myopia: a systematic review. Asia Pac J Ophthalmol. 2024. PMID 39672511.
44. National Eye Institute. Retinal Detachment. Updated 5 November 2025.
